1246617-50-4

Basic information

• Product Name: C₁₆H₁₆N₂O₃
• Synonyms: C₁₆H₁₆N₂O₃
• CAS NO: 1246617-50-4
• Molecular Weight: 284.315
• Mol File: 1246617-50-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₁₆H₁₆N₂O₃(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₆H₁₆N₂O₃(1246617-50-4)
• EPA Substance Registry System: C₁₆H₁₆N₂O₃(1246617-50-4)

Safety Data

• Hazardous Substances Data: 1246617-50-4(Hazardous Substances Data)

Upstream product

• 765-30-0 Cyclopropylamine 
• 119736-16-2 3-(benzyloxy)-1-((tert-butoxycarbonyl)amino)-4-oxo-1,4-dihydropyridine-2-carboxylic acid ethyl ester 
• 1246617-42-4 3-(benzyloxy)-4-oxo-1,4-dihydropyridine-2-carboxylic acid hydrochloride 

Downstream Products

• 1246617-51-5 C₁₆H₁₇N₃O₃ 
• 1246617-52-6 C₁₇H₁₇N₃O₃ 
• 1246617-53-7 C₃₀H₂₇N₃O₃ 
• 1246617-54-8 C₂₃H₂₁N₃O₃ 

Relevant articles and documents

Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor

This work describes a set of discovery research studies of an influenza cap-dependent endonuclease (CEN) inhibitor with a carbamoyl pyridone bicycle (CAB) scaffold. Using influenza CEN inhibitory activity, antiviral activity and pharmacokinetic (PK) parameters as indices, structure activity relationships (SAR) studies were performed at the N-1 and N-3 positions on the CAB scaffold, which is a unique template to bind two metals. The hydrophobic substituent at the N-1 position is extremely important for CEN inhibitory activity and antiviral activity, and dihydrodibenzothiepine is the most promising pharmacophore. The compound (S)-13i showed potent virus titer reduction over oseltamivir phosphate in an in vivo mouse model. The CAB compound described herein served as the lead compound of baloxavir marboxil with a tricyclic scaffold, which was approved in Japan and the USA in 2018.